Search alternatives:
"au_ values decrease" » "au_ values increased" (Expand Search), "au_ largest decrease" (Expand Search), "auc values decrease" (Expand Search), "_ values decrease" (Expand Search), "all values decrease" (Expand Search)
"i values decrease" » "i values increased" (Expand Search), "i largest decrease" (Expand Search), "_ values decrease" (Expand Search)
"c cases increased" » "c levels increased" (Expand Search), "c cycles increases" (Expand Search), "ic cases increased" (Expand Search), "c2 cases increased" (Expand Search), "_ cases increased" (Expand Search)
"au_ values decrease" » "au_ values increased" (Expand Search), "au_ largest decrease" (Expand Search), "auc values decrease" (Expand Search), "_ values decrease" (Expand Search), "all values decrease" (Expand Search)
"i values decrease" » "i values increased" (Expand Search), "i largest decrease" (Expand Search), "_ values decrease" (Expand Search)
"c cases increased" » "c levels increased" (Expand Search), "c cycles increases" (Expand Search), "ic cases increased" (Expand Search), "c2 cases increased" (Expand Search), "_ cases increased" (Expand Search)
-
1
Figure 2 from mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of <i>PIK3CA</i>-Altered Tumors
Published 2025“…Node size increases as the <i>P</i>-value decreases. <b>B,</b> Top 20 canonical pathways that are significantly differentially activated between clinical benefit (CB) and no clinical benefit (NCB) groups, based on assessment with Fisher’s exact test in Qiagen IPA. …”